AD ASTRA (Androgen Deprivation with Apalutamide and STereotactic RAdiotherapy)Prospective institutional phase II study of efficacy and safety of androgen deprivation with apalutamide in high-risk prostate cancer patients treated with extremely hypofractionated stereotactic radiotherapy. - AD ASTRA
Prospective, multicentre phase II study of de-escalation of primary chemoradiotherapy of squamous cell carcinoma of oropharynx (OPC) associated with human papilloma virus (HPV) - NaDeJ
100 Clinical Results associated with Východoslovenský onkologický ústav AS
0 Patents (Medical) associated with Východoslovenský onkologický ústav AS
100 Deals associated with Východoslovenský onkologický ústav AS
100 Translational Medicine associated with Východoslovenský onkologický ústav AS